Viewing Study NCT03960450


Ignite Creation Date: 2025-12-24 @ 4:45 PM
Ignite Modification Date: 2026-01-27 @ 12:26 AM
Study NCT ID: NCT03960450
Status: COMPLETED
Last Update Posted: 2020-11-18
First Post: 2019-05-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Repeat Topical Administration of BOS-475 in Healthy Subjects and Patients With Psoriasis
Sponsor: Boston Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Psoriasis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Psoriasis View
None BOS-475 View